Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort

Open access

Abstract

Transcranial Doppler (TCD) is used to detect children with sickle cell anemia (SCA) who are at risk for stroke, and transfusion programs significantly reduce stroke risk in patients with abnormal TCD. We describe the predictive factors and outcomes of cerebral vasculopathy in the Créteil newborn SCA cohort (n = 217 SS/Sβ0), who were early and yearly screened with TCD since 1992. Magnetic resonance imaging/magnetic resonance angiography was performed every 2 years after age 5 (or earlier in case of abnormal TCD). A transfusion program was recommended to patients with abnormal TCD and/or stenoses, hydroxyurea to symptomatic patients in absence of macrovasculopathy, and stem cell transplantation to those with human leukocyte antigen-genoidentical donor. Mean follow-up was 7.7 years (1609 patient-years). The cumulative risks by age 18 years were 1.9% (95% confidence interval [95% CI] 0.6%-5.9%) for overt stroke, 29.6% (95% CI 22.8%-38%) for abnormal TCD, which reached a plateau at age 9, whereas they were 22.6% (95% CI 15.0%-33.2%) for stenosis and 37.1% (95% CI 26.3%-50.7%) for silent stroke by age 14. Cumulating all events (stroke, abnormal TCD, stenoses, silent strokes), the cerebral risk by age 14 was 49.9% (95% CI 40.5%-59.3%); the independent predictive factors for cerebral risk were baseline reticulocytes count (hazard ratio 1.003/L × 109/L increase, 95% CI 1.000-1.006; P = .04) and lactate dehydrogenase level (hazard ratio 2.78/1 IU/mL increase, 95% CI1.33-5.81; P = .007). Thus, early TCD screening and intensification therapy allowed the reduction of stroke-risk by age 18 from the previously reported 11% to 1.9%. In contrast, the 50% cumulative cerebral risk suggests the need for more preventive intervention.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2010-06-293514

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Research works printed but not linked: 3

  1. Bernaudin, 2001, Early cerebral exploration with transcranial Doppler (TCD) in patients with sickle cell disease: effects of age and risk factors on velocities [abstract]., Blood, 98, 784a
  2. Bernaudin, 1999, Hydroxyurea (HU) therapy improves cognitive functioning in sickle cell disease (SCD) patients [abstract]., Blood, 94
  3. Arnaud, 2008, Comparaison de l'efficacité et du coût de l'Hydréa, du programme transfusionnel et de la greffe de cellules souches sur 76 enfants drépanocytaires avec fréquentes crises vaso-occlusives et ou syndromes thoraciques., Hématologie, 14, 31

Cited by

See all 336

Metadata

Authors
Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coïc, L., Leveillé, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galactéros, F., Torres, M., Kuentz, M., Ferry, C., Socié, G., Reinert, P., & Delacourt, C.
Affiliations
  • Hôpital Saint-Louis (FR)
  • Hôpital Intercommunal de Créteil (FR)
  • Pediatrics, Referral Center for Sickle Cell Disease, Centre Hospitalier Intercommunal, Créteil, France;
  • Biochemistry, Henri Mondor Hospital, Créteil, France;
  • Centre Hospitalier Universitaire Henri-Mondor (FR)
  • Pediatrics, University of Southern California, Los Angeles, Los Angeles, California; and
  • Hematology, Saint-Louis Hospital, Paris, France;
Venue
Blood
Published
2011-01-27
Volume
117
Issue
4
Pages
1130-1140
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1978242664
Cited by
336
References
49
Citations by year
2026: 8 · 2025: 11 · 2024: 14 · 2023: 17 · 2022: 23 · 2021: 26 · 2020: 23 · 2019: 20 · 2018: 21 · 2017: 29 · 2016: 37 · 2015: 20 · 2014: 26 · 2013: 27 · 2012: 23
FWCI
8.51
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
sickle cell disease, transcranial Doppler screening, cerebral vasculopathy, stroke risk, cerebral stenosis, silent stroke, hydroxyurea, transfusion therapy, stem cell transplantation, reticulocyte count, lactate dehydrogenase, predictive factors, macroangiopathy, magnetic resonance angiography
MeSH terms
Anemia, Sickle Cell, Cerebral Arterial Diseases, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Infant, Newborn, Diseases, Male, Time Factors, Cohort Studies, Neonatal Screening, Treatment Outcome, Ultrasonography, Doppler, Transcranial, Magnetic Resonance Angiography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. https://app.cochat.ai/papers/10.1182/blood-2010-06-293514
The paper
Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coïc, L., Leveillé, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galactéros, F., Torres, M., Kuentz, M., . . . Delacourt, C. (2011). Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood. https://doi.org/10.1182/blood-2010-06-293514

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.